Neurocrine Biosciences, Inc.

NasdaqGS:NBIX 株式レポート

時価総額:US$12.5b

Neurocrine Biosciences マネジメント

マネジメント 基準チェック /44

Neurocrine Biosciencesの CEO はKyle Ganoで、 Jan2011年に任命され、 の在任期間は 13.83年です。 の年間総報酬は$ 5.99Mで、 10.1%給与と89.9%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.13%を直接所有しており、その価値は$ 16.69M 。経営陣と取締役会の平均在任期間はそれぞれ6.9年と9.1年です。

主要情報

Kyle Gano

最高経営責任者

US$6.0m

報酬総額

CEO給与比率10.1%
CEO在任期間13.8yrs
CEOの所有権0.1%
経営陣の平均在職期間6.9yrs
取締役会の平均在任期間9.1yrs

経営陣の近況

Recent updates

Neurocrine: A Buy Amid CNS Pipeline Growth And Ingrezza's Strength (Rating Upgrade)

Oct 10

The Play On Neurocrine Biosciences

Oct 02

Neurocrine: Buying Opportunity After Stock Price Drop On Schizophrenia Data

Aug 28

Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly

Jul 28
Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly

Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth

Jul 09

Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality

May 08
Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality

Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Apr 27
Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data

Apr 25

Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly

Mar 31
Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly

Neurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional Upside

Feb 11

Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Jan 07
Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Neurocrine Biosciences (NASDAQ:NBIX) Could Easily Take On More Debt

Dec 11
Neurocrine Biosciences (NASDAQ:NBIX) Could Easily Take On More Debt

Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?

Sep 12
Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?

We Think Neurocrine Biosciences (NASDAQ:NBIX) Can Manage Its Debt With Ease

Jun 08
We Think Neurocrine Biosciences (NASDAQ:NBIX) Can Manage Its Debt With Ease

CEO報酬分析

Neurocrine Biosciences の収益と比較して、Kyle Gano の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$386m

Jun 30 2024n/an/a

US$339m

Mar 31 2024n/an/a

US$370m

Dec 31 2023US$6mUS$603k

US$250m

Sep 30 2023n/an/a

US$191m

Jun 30 2023n/an/a

US$176m

Mar 31 2023n/an/a

US$64m

Dec 31 2022US$5mUS$551k

US$155m

Sep 30 2022n/an/a

US$58m

Jun 30 2022n/an/a

US$12m

Mar 31 2022n/an/a

US$71m

Dec 31 2021US$6mUS$517k

US$90m

Sep 30 2021n/an/a

US$445m

Jun 30 2021n/an/a

US$365m

Mar 31 2021n/an/a

US$402m

Dec 31 2020US$7mUS$488k

US$407m

Sep 30 2020n/an/a

US$93m

Jun 30 2020n/an/a

US$205m

Mar 31 2020n/an/a

US$177m

Dec 31 2019US$5mUS$443k

US$37m

Sep 30 2019n/an/a

US$21m

Jun 30 2019n/an/a

US$18m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018US$5mUS$403k

US$21m

Sep 30 2018n/an/a

US$10m

Jun 30 2018n/an/a

-US$52m

Mar 31 2018n/an/a

-US$106m

Dec 31 2017US$2mUS$375k

-US$143m

報酬と市場: Kyleの 総報酬 ($USD 5.99M ) は、 US市場 ($USD 12.73M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Kyleの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Kyle Gano (51 yo)

13.8yrs

在職期間

US$5,990,215

報酬

Mr. Kyle W. Gano, Ph D., is CEO and Director at Neurocrine Biosciences, Inc since October 11, 2024. He was Chief Business Development and Strategy Officer at Neurocrine Biosciences, Inc. since 2020 until O...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Kyle Gano
CEO & Director13.8yrsUS$5.99m0.13%
$ 16.7m
Matthew Abernethy
Chief Financial Officer7yrsUS$6.06m0.031%
$ 3.9m
Jude Onyia
Chief Scientific Officer3yrsUS$7.22m0.013%
$ 1.6m
Eiry Roberts
Chief Medical Officer6.8yrsUS$5.87m0.031%
$ 3.8m
Jane Sorensen
Head of Investor Relationsno dataデータなしデータなし
Darin Lippoldt
Chief Legal Officer & Corporate Secretary10.1yrsUS$4.72m0.039%
$ 4.9m
Julie Cooke
Chief Human Resources Officer7.2yrsデータなし0.018%
$ 2.2m
Eric Benevich
Chief Commercial Officer9.5yrsUS$5.81m0.040%
$ 5.0m
David Boyer
Chief Corporate Affairs Officer5.2yrsデータなし0.00037%
$ 46.2k
Ingrid Delaet
Chief Regulatory Officer2.1yrsデータなし0.0025%
$ 309.6k
Christopher O'Brien
Exclusive Consultant6.8yrsUS$3.10mデータなし

6.9yrs

平均在職期間

58yo

平均年齢

経験豊富な経営陣: NBIXの経営陣は経験豊富で経験豊富です(平均在職期間は6.9年)。


取締役

名称ポジション在職期間報酬所有権
Kyle Gano
CEO & Directorless than a yearUS$5.99m0.13%
$ 16.7m
Christine Poon
Independent Director1.3yrsUS$813.45k0%
$ 0
Richard Pops
Independent Director26.6yrsUS$492.04k0.031%
$ 3.9m
Stephen Sherwin
Independent Director25.6yrsUS$479.54k0.024%
$ 3.0m
William Rastetter
Independent Chairman of the Board14.8yrsUS$495.04k0.037%
$ 4.6m
Gary Lyons
Independent Director31.8yrsUS$460.11k0.12%
$ 14.7m
George Morrow
Independent Director9.1yrsUS$479.54k0.0042%
$ 518.0k
Kevin Gorman
Director16.8yrsUS$15.75m0.51%
$ 63.4m
Shalini Sharp
Independent Director4.8yrsUS$497.11k0.00098%
$ 122.3k
Leslie Norwalk
Independent Director5.2yrsUS$475.11k0.00098%
$ 122.3k
Johanna Mercier
Independent Director3.6yrsUS$467.61k0.0021%
$ 258.4k

9.1yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: NBIXの 取締役会経験豊富 であると考えられます ( 9.1年の平均在任期間)。